El código SA/NC 300360 se considera fuera del ámbito para la preparación EUDR.
Medicaments containing any of the following antimalarial active principles: artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN), not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail sale El motor de ámbito indexado devuelve Out of scope para este código. No Annex I scope match was found for this indexed CN code.
Por qué esta página de referencia da esa respuesta.
- Descripción del código
- Medicaments containing any of the following antimalarial active principles: artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN), not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail sale
- Base en el anexo I
- Sin entrada directa en el anexo I
- Base de la fuente
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Filas superiores, inferiores y próximas.
La vista de biblioteca es para la navegación de referencia. Use el comprobador cuando quiera ejecutar otro código como acción.
30productos farmacéuticosout3003medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006)out30036000medicaments containing any of the following antimalarial active principles: artemisinin (inn) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (inn); artelinic acid or its salts; artenimol (inn); artemotil (inn); artemether (inn); artesunate (inn); chloroquine (inn); dihydroartemisinin (inn); lumefantrine (inn); mefloquine (inn); piperaquine (inn); pyrimethamine (inn) or sulfadoxine (inn), not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout300310medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof, not in measured doses or put up for retail saleout300320medicaments containing antibiotics, not in measured doses or put up for retail sale (excl. medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof)out300331medicaments containing insulin, not in measured doses or put up for retail saleout300339medicaments containing hormones or steroids used as hormones, not containing antibiotics, not in measured doses or put up for retail sale (excl. those containing insulin)out300340medicaments containing alkaloids or derivatives thereof, not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout300341medicaments containing ephedrine or its salts, not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout
Qué significa esto para la preparación.
Esta fila no activa directamente la recogida de pruebas en el resultado de ámbito actual.
Regulation (EU) 2023/1115 Annex I — relevant productsconsultado el 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115consultado el 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)consultado el 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)consultado el 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8consultado el 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingconsultado el 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersconsultado el 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)consultado el 2026-08-08